Clinical Classification of Pain in Breast Cancer Survivors
NCT ID: NCT04219072
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2023-07-01
2023-10-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery
NCT06052085
The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors
NCT04531917
Symptoms Associated with Chemotherapy-Induced Peripheral Neuropathy
NCT06352567
PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS
NCT04730154
Pain, Nutrition and Glycemic Response in Chronic Low Back Pain and Breast Cancer Survivors
NCT04459104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* completed remission and their primary treatment at least 3 months prior to study participation
* experienced pain or a sensitive disorder (like numbness, tingling, etc.) anywhere in body for which they stated a minimum score of 3 on a numeric pain rating scale
Exclusion Criteria
* severe psychological disorders
* active metastases
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vrije Universiteit Brussel
OTHER
Kutahya Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ismail Saracoglu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KutahyaMSU
Kütahya, Kutahya Health Sciences University, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KutahyaMSUcancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.